Daclatasvir
Daclatasvir is a direct-acting antiviral used with other active medicines for chronic hepatitis C. It is not a complete hepatitis C treatment by itself.
Key points
- The full regimen depends on viral and liver factors and must be completed as prescribed to avoid treatment failure.
- Hepatitis B status and extensive medicine and herbal interactions require review before treatment.
- Fainting, a very slow heartbeat, jaundice or severe abdominal swelling needs urgent assessment.
Listings are for comparison only. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.
How it works
Daclatasvir blocks the hepatitis C NS5A protein, disrupting viral replication and assembly. Other antiviral components are needed to clear infection effectively.
Important safety checks
Hepatitis B coinfection, liver function, pregnancy considerations for the complete regimen and all medicines and supplements require review. Strong enzyme inducers can make treatment fail. Certain regimens combined with amiodarone can cause dangerous bradycardia.
When to seek urgent care
Seek urgent help for fainting, marked weakness with a very slow heartbeat, yellow skin or eyes, vomiting blood, black stools, severe abdominal swelling, confusion or a serious allergic reaction.